<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00540098</url>
  </required_header>
  <id_info>
    <org_study_id>290060/552</org_study_id>
    <nct_id>NCT00540098</nct_id>
  </id_info>
  <brief_title>Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder</brief_title>
  <acronym>Exparox</acronym>
  <official_title>A Randomized, Controlled Trial on the Effects of Paroxetine Versus Placebo in Combination With Aerobic Exercise or Relaxation Training in the Treatment of Panic Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Göttingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Göttingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy and safety of a 10-weeks treatment protocol of paroxetine vs. placebo in combination
      with regular aerobic exercise (running) or regular relaxation training in the treatment of
      panic disorder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In continuation of prior work from our group (Broocks A, Bandelow B, Pekrun G, et al.
      Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.
      Am J Psychiatry 1998; 155(5):603-9.) it is the purpose of this trial to test the assumed
      superiority of a combined therapy of paroxetine and aerobic exercise compared to placebo or
      unspecific relaxation training in panic disorder. Participants were randomized to a 10 week
      treatment protocol of paroxetine 40 mg daily or placebo in combination with regular exercise
      or regular relaxation after having given informed consent and screening of in- and exclusion
      criteria.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2001</start_date>
  <completion_date type="Actual">June 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of Panic disorder due to Scores on the Panic and Agoraphobia Scale (P&amp;A)</measure>
    <time_frame>Baseline to endpoint (10 weeks)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of panic disorder due to scores on the Clinical Global Impression scale (CGI)</measure>
    <time_frame>Baseline to endpoint (10 weeks)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom severity due to Hamilton Anxiety Scale (HAMA)</measure>
    <time_frame>Baseline to endpoint (10 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom severity due to the Montgomery and Asberg depression rating scale (MADRS)</measure>
    <time_frame>Baseline to endpoint (10 weeks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response and remission analysis between groups</measure>
    <time_frame>LOCF-analysis</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Panic Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Paroxetine + aerobic exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paroxetine + relaxation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placebo + aerobic exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo + relaxation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paroxetine + aerobic exercise</intervention_name>
    <description>paroxetine, 40 mg once daily + regular aerobic exercise</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paroxetine + relaxation</intervention_name>
    <description>paroxetine, 40 mg once daily + regular relaxation training</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo + aerobic exercise</intervention_name>
    <description>placebo pill once daily + regular aerobic exercise</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo + relaxation</intervention_name>
    <description>placebo pill once daily + regular relaxation training</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Panic disorder with or without agoraphobia due to DSM-IV

          -  Written informed consent

          -  Score of 17 or more on the P&amp;A scale

          -  Score on the CGI of 4 or more (markedly ill)

        Exclusion Criteria:

          -  Pregnancy, lactating or insufficient contraception (pearl index &gt;1)

          -  Other psychiatric disorders such as psychoses, addictive disorders, dementia, etc.

          -  Clinically relevant abnormalities in physical examination or laboratory results

          -  Prior major depression or bipolar disorder

          -  Suicidality

          -  psychotropic medication other than promethazine

          -  current psychological treatment

          -  unable to perform regular aerobic exercise
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borwin Bandelow, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Göttingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Göttingen, Dept of Psychiatry and Psychotherapy</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, Hillmer-Vogel U, Rüther E. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry. 1998 May;155(5):603-9.</citation>
    <PMID>9585709</PMID>
  </reference>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2007</study_first_submitted>
  <study_first_submitted_qc>October 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2007</study_first_posted>
  <last_update_submitted>October 4, 2007</last_update_submitted>
  <last_update_submitted_qc>October 4, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2007</last_update_posted>
  <keyword>panic disorder</keyword>
  <keyword>pharmacotherapy</keyword>
  <keyword>non-pharmacological treatment</keyword>
  <keyword>SSRI</keyword>
  <keyword>paroxetine</keyword>
  <keyword>exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paroxetine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

